Market Expansion
HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
Indian Biosimilars on the Global Stage: HRV Pharma CEO's Insights in Express Pharma
India's rise in biosimilars & biologics. Full clipping + insights included.
GLP-1 Patents Are Fading - Can India Become the GLP-1 Generics Powerhouse
As GLP-1 patents expire, India’s manufacturing scale, peptide chemistry expertise, and compliance readiness could position it to supply affordable GLP-1 generics globally — but consistency and supply reliability will decide who wins
Breaking the Factory Wall: How Virtual Pharma is Democratizing Global Drug Access
HRV Pharma's CEO Hari Kiran Chereddi explores how virtual pharmaceutical manufacturing is revolutionizing global drug access by breaking traditional factory-based models and democratizing healthcare through agile, compliant supply chains.